Interleukin-1 receptor antagonist inhibits pulmonary hypertension induced by inflammation.
Division of Pulmonary and Critical Care Medicine, University of Colorado Health Sciences Center, Denver 80202.
N F
NF
Voelkel
R
R
Tuder
D000818:Animals; D001794:Blood Pressure; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000517:prevention & control*; D017380:Hypertrophy, Right Ventricular / Q000139:chemically induced / Q000517:prevention & control; D000860:Hypoxia; D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1 / Q000235:genetics / Q000378:metabolism; D008168:Lung / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D016686:Monocrotaline / Q000494:pharmacology; D009929:Organ Size; D011651:Pulmonary Artery / Q000502:physiology; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors*; D012795:Sialoglycoproteins / Q000378:metabolism / Q000494:pharmacology*
D053590:Interleukin 1 Receptor Antagonist Protein; D007375:Interleukin-1; D012333:RNA, Messenger; D017472:Receptors, Interleukin-1; D012795:Sialoglycoproteins; D016686:Monocrotaline